4 About the Compound Dihexa is a small synthetic oligopeptide derived from the three N-terminal residues of angiotensin IV (Nle-Tyr-Ile), with structural modifications that block enzymatic degradation, increase lipophilicity, and confer oral bioavailability and blood-brain barrier permeability
It is a combination of the 2 most famous BPC-157 and TB-500 into a peptide blend
This is the window that the Finkley 2005 trial captured, and the Carey/Pickart ultrasound work confirmed at the structural level: an average 28% increase in collagen density, with top responders at 51%
You're a good candidate if you have: Plantar fasciitis for more than 3 months Failed conservative treatments (rest, PT, orthotics) Want to avoid surgery Need to return to high-level activity Will Insurance Cover It
Stacking it with other peptides such as CJC-1295, ipamorelin, BPC-157, or TB-500 carries unknown and potentially serious risks
Delivered via nasal spray, it bypasses the skin barrier entirely and activates collagen pathways from within
